• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从科学发现到癫痫治疗的途径。

The path from scientific discovery to cures for epilepsy.

机构信息

Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.

Department of Neuroscience, Tufts University School of Medicine, Boston, MA, USA.

出版信息

Neuropharmacology. 2020 May 1;167:107702. doi: 10.1016/j.neuropharm.2019.107702. Epub 2019 Jul 10.

DOI:10.1016/j.neuropharm.2019.107702
PMID:31301334
Abstract

The epilepsies are a complex group of disorders that can be caused by a myriad of genetic and acquired factors. As such, identifying interventions that will prevent development of epilepsy, as well as cure the disorder once established, will require a multifaceted approach. Here we discuss the progress in scientific discovery propelling us towards this goal, including identification of genetic risk factors and big data approaches that integrate clinical and molecular 'omics' datasets to identify common pathophysiological signatures and biomarkers. We discuss the many animal and cellular models of epilepsy, what they have taught us about pathophysiology, and the cutting edge cellular, optogenetic, chemogenetic and anti-seizure drug screening approaches that are being used to find new cures in these models. Finally, we reflect on the work that still needs to be done towards identify at-risk individuals early, targeting and stopping epileptogenesis, and optimizing promising treatment approaches. Ultimately, developing and implementing cures for epilepsy will require a coordinated and immense effort from clinicians and basic scientists, as well as industry, and should always be guided by the needs of individuals affected by epilepsy and their families. This article is part of the special issue entitled 'New Epilepsy Therapies for the 21st Century - From Antiseizure Drugs to Prevention, Modification and Cure of Epilepsy'.

摘要

癫痫是一组复杂的疾病,可能由多种遗传和获得性因素引起。因此,要确定可以预防癫痫发作的干预措施,以及一旦癫痫发作可以治愈该疾病的方法,就需要采取多方面的方法。在这里,我们讨论推动我们向这一目标前进的科学发现进展,包括鉴定遗传风险因素和大数据方法,这些方法整合了临床和分子“组学”数据集,以确定常见的病理生理特征和生物标志物。我们讨论了许多癫痫动物和细胞模型,它们让我们了解了病理生理学,以及用于在这些模型中寻找新治疗方法的前沿细胞、光遗传学、化学遗传学和抗癫痫药物筛选方法。最后,我们反思了仍然需要做的工作,以便早期识别风险个体,靶向和阻止癫痫发生,并优化有前途的治疗方法。最终,开发和实施癫痫治疗方法需要临床医生和基础科学家、行业的协调和巨大努力,并且应该始终以受癫痫影响的个人及其家庭的需求为指导。本文是题为“21 世纪的新癫痫治疗方法——从抗癫痫药物到癫痫的预防、干预和治疗”的特刊的一部分。

相似文献

1
The path from scientific discovery to cures for epilepsy.从科学发现到癫痫治疗的途径。
Neuropharmacology. 2020 May 1;167:107702. doi: 10.1016/j.neuropharm.2019.107702. Epub 2019 Jul 10.
2
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.抗癫痫药物(ASD)发现的验证动物模型:ASD 筛选中的优势和潜在陷阱。
Neuropharmacology. 2020 May 1;167:107750. doi: 10.1016/j.neuropharm.2019.107750. Epub 2019 Aug 27.
3
A systems-level framework for anti-epilepsy drug discovery.一种用于抗癫痫药物发现的系统级框架。
Neuropharmacology. 2020 Jun 15;170:107868. doi: 10.1016/j.neuropharm.2019.107868. Epub 2019 Nov 28.
4
Stem cells: A path towards improved epilepsy therapies.干细胞:通往改善癫痫治疗的道路。
Neuropharmacology. 2020 May 15;168:107781. doi: 10.1016/j.neuropharm.2019.107781. Epub 2019 Sep 17.
5
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.癫痫治疗筛选计划合同网站当前的方法是为识别改善治疗药物难治性癫痫发作的治疗方法。
Neuropharmacology. 2020 Apr;166:107811. doi: 10.1016/j.neuropharm.2019.107811. Epub 2019 Nov 30.
6
Optogenetic and chemogenetic therapies for epilepsy.用于癫痫的光遗传学和化学遗传学疗法。
Neuropharmacology. 2020 May 15;168:107751. doi: 10.1016/j.neuropharm.2019.107751. Epub 2019 Sep 5.
7
Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies.基于代谢的斑马鱼药物发现:揭示新型抗癫痫治疗策略的新兴策略。
Neuropharmacology. 2020 May 1;167:107988. doi: 10.1016/j.neuropharm.2020.107988. Epub 2020 Feb 4.
8
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.癫痫预防的圣杯:抗癫痫发生治疗的临床前方法。
Neuropharmacology. 2020 May 1;167:107605. doi: 10.1016/j.neuropharm.2019.04.011. Epub 2019 Apr 11.
9
Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.表观遗传学与癫痫预防:腺苷和代谢疗法的治疗潜力。
Neuropharmacology. 2020 May 1;167:107741. doi: 10.1016/j.neuropharm.2019.107741. Epub 2019 Aug 13.
10
Biomarkers for epileptogenesis and its treatment.癫痫发生及其治疗的生物标志物。
Neuropharmacology. 2020 May 1;167:107735. doi: 10.1016/j.neuropharm.2019.107735. Epub 2019 Aug 1.

引用本文的文献

1
The Upregulation of L1CAM by SVHRSP Mitigates Neuron Damage, Spontaneous Seizures, and Cognitive Dysfunction in a Kainic Acid-Induced Rat Model of Epilepsy.在海人酸诱导的大鼠癫痫模型中,SVHRSP对L1CAM的上调减轻了神经元损伤、自发性癫痫发作和认知功能障碍。
Biomolecules. 2025 Jul 17;15(7):1032. doi: 10.3390/biom15071032.
2
Epileptic Patients with More Clinic Visits Are More Likely to Be Diagnosed with Dementia-A Population-Based Retrospective Cohort Study.门诊就诊次数较多的癫痫患者更易被诊断为痴呆——一项基于人群的回顾性队列研究
Diagnostics (Basel). 2024 Dec 6;14(23):2748. doi: 10.3390/diagnostics14232748.
3
New epilepsy therapies in development.
正在开发的新癫痫疗法。
Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22.
4
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments.耐药性癫痫的动物模型作为破译药物抵抗的细胞和分子机制以及发现更有效的治疗方法的工具。
Cells. 2023 Apr 24;12(9):1233. doi: 10.3390/cells12091233.
5
Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: Emerging preclinical evidence of druggability.针对癫痫发作和癫痫的药理学靶向瞬时受体电位通道:有潜力成为药物的新兴临床前证据。
Pharmacol Ther. 2023 Apr;244:108384. doi: 10.1016/j.pharmthera.2023.108384. Epub 2023 Mar 16.
6
TRPC channels as emerging targets for seizure disorders.TRPC 通道作为癫痫疾病的新兴靶点。
Trends Pharmacol Sci. 2022 Sep;43(9):787-798. doi: 10.1016/j.tips.2022.06.007. Epub 2022 Jul 12.
7
Dogs as a Natural Animal Model of Epilepsy.狗作为癫痫的天然动物模型。
Front Vet Sci. 2022 Jun 22;9:928009. doi: 10.3389/fvets.2022.928009. eCollection 2022.
8
Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects.新型吡唑类化合物抑制 TRPC3 通道发挥抗癫痫作用。
Epilepsia. 2022 Apr;63(4):1003-1015. doi: 10.1111/epi.17190. Epub 2022 Feb 18.
9
Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics.癫痫的液体活检:病因学、诊断、预后和治疗的生物标志物。
Hum Cell. 2022 Jan;35(1):15-22. doi: 10.1007/s13577-021-00624-x. Epub 2021 Oct 25.
10
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.抗癫痫药物的药理学和临床疗效:从溴化物盐到依诺巴比妥及其他。
CNS Drugs. 2021 Sep;35(9):935-963. doi: 10.1007/s40263-021-00827-8. Epub 2021 Jun 18.